<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04526392</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/19/0497</org_study_id>
    <nct_id>NCT04526392</nct_id>
  </id_info>
  <brief_title>Pubertal Evolutionary Profile of Children Monitored for Fetal Ovarian Cyst</brief_title>
  <acronym>KOF</acronym>
  <official_title>Pubertal Evolutionary Profile of Children Monitored for Fetal Ovarian Cyst</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is based on pubertal surveillance of fetal ovarian cysts (KOF). Fetal ovarian&#xD;
      cysts (KOF) detected during fetal ultrasound examinations occur during the 3rd trimester of&#xD;
      pregnancy and are of unknown cause.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      These cysts are functional in the vast majority of cases and are therefore likely to&#xD;
      disappear spontaneously, but they may become complicated before regressing. Apart from&#xD;
      complication, the natural evolution of these cysts, which are said to be &quot;simple&quot; because&#xD;
      they are liquid on ultrasound, is towards regression in the first months of neo-natal life.&#xD;
&#xD;
      Surveillance during the 1st year of life showed that simple cysts regressed during the 1st&#xD;
      trimester. In the case of complicated cysts, oophorectomy was necessary in 9 cases. In the&#xD;
      1-year follow-up, the ovarian recovery rate was significantly different depending on the&#xD;
      appearance of the cyst (p&lt;0.0001); 60 ovaries out of 89 homolateral to the cyst were&#xD;
      follicular, of which 48/49 (98%) were carriers of fluid cysts and 12/40 (30%) were initially&#xD;
      heterogeneous. The origin of these cysts is unknown, the ovary is again physiologically&#xD;
      stimulated during the onset of puberty. No series in the literature gives the long-term&#xD;
      ovarian prognosis for these patients. We wish to evaluate the pubertal evolutionary profile&#xD;
      of patients followed at the University Hospital for KOF. The data collected concerning&#xD;
      puberty (age of menses) will be examined in relation to the age of menses in the siblings and&#xD;
      in the mother, as well as to the data in the literature on the age of the first menses in&#xD;
      France.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 6, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Age of onset of first menstruation</measure>
    <time_frame>Day 1</time_frame>
    <description>Age of onset of first menstruation defined with one decimal place (year and month).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average age of maternal and sister rules</measure>
    <time_frame>Day 1</time_frame>
    <description>Average age of maternal and sister menstruation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ovarian volumes</measure>
    <time_frame>Day 1</time_frame>
    <description>Homo and contralateral ovarian volumes at the cyst.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence or not of follicles</measure>
    <time_frame>Day 1</time_frame>
    <description>Presence or not of follicles on both ovaries.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first menstruation description - age of breast onset</measure>
    <time_frame>Day 1</time_frame>
    <description>Age of breast onset</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first menstruation description - cycle length</measure>
    <time_frame>Day 1</time_frame>
    <description>cycle length in the last three months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first menstruation description - cycle disorder</measure>
    <time_frame>Day 1</time_frame>
    <description>rate of patients with cycle disorder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first menstruation description dysmenorrhoea.</measure>
    <time_frame>Day 1</time_frame>
    <description>dysmenorrhoea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first menstruation description menorrhagia</measure>
    <time_frame>Day 1</time_frame>
    <description>menorrhagia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentage of hyperandrogenism</measure>
    <time_frame>Day 1</time_frame>
    <description>Percentage of girls with clinical signs of hyperandrogenism or elevated testosterone levels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormonal levels - AMH</measure>
    <time_frame>Day 1</time_frame>
    <description>AMH levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormonal levels - LH</measure>
    <time_frame>Day 1</time_frame>
    <description>Luteinizing hormone (LH) levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormonal levels - FSH</measure>
    <time_frame>Day 1</time_frame>
    <description>follicle stimulating hormone (FSH) levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormonal levels - estradiol</measure>
    <time_frame>Day 1</time_frame>
    <description>estradiol levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of ovarian cyst recurrence</measure>
    <time_frame>Day 1</time_frame>
    <description>Ovarian cyst recurrence rate</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">83</enrollment>
  <condition>Fetal Ovarian Cyst</condition>
  <arm_group>
    <arm_group_label>Questionnaire</arm_group_label>
    <description>Patients will choose how they wish to complete the Pubertal Course Questionnaire: electronically (web link), on paper, by telephone, or face-to-face at a follow-up consultation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Pubertal course questionnaire</description>
    <arm_group_label>Questionnaire</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Young girls who have to answer a questionnaire on their pubertal development. Estimated&#xD;
        duration of data collection by questionnaire for one participant: 30 minutes maximum.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients at least 8 years of age at the time of inclusion.&#xD;
&#xD;
          -  Patients being followed for fetal ovarian cyst.&#xD;
&#xD;
          -  Minor patients of whom at least one of the two holders of parental authority has given&#xD;
             his or her non-opposition.&#xD;
&#xD;
          -  Patients covered by a social security scheme.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients less than 8 years of age at the time of inclusion&#xD;
&#xD;
          -  Ovarian cysts outside the neonatal period&#xD;
&#xD;
          -  Refusal to participate.&#xD;
&#xD;
          -  Opposition to disclosure of neonatal data.&#xD;
&#xD;
          -  Pregnant or nursing patient.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Catherine PIENKOWSKI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Toulouse University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine PIENKOWSKI, MD</last_name>
    <phone>5 34 55 85 53</phone>
    <phone_ext>+33</phone_ext>
    <email>pienkowski.c@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Toulouse University Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine PIENKOWSKI, MD</last_name>
      <phone>5 34 55 85 53</phone>
      <phone_ext>+33</phone_ext>
      <email>pienkowski.c@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine PIENKOWSKI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 29, 2020</study_first_submitted>
  <study_first_submitted_qc>August 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>August 24, 2020</last_update_submitted>
  <last_update_submitted_qc>August 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>child</keyword>
  <keyword>puberty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cysts</mesh_term>
    <mesh_term>Ovarian Cysts</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

